Atlas Trials

Pevonedistat With Azacitidine Versus Azacitidine Alone in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT03745352 · WITHDRAWN

Trial details

NCT number
NCT03745352
Sponsor
National Cancer Institute (NCI)
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
Start date
2019-05-20
Primary completion
2021-08-19
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.